Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-19-000609
Filing Date
2019-06-14
Accepted
2019-06-14 11:10:48
Documents
1
Period of Report
2019-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_6153.html 4  
1 PRIMARY DOCUMENT doc4_6153.xml 4 3767
  Complete submission text file 0001638599-19-000609.txt   5180
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 SPRING ROAD CONCORD MA 01742
Business Address
Ono Richard Dana (Reporting) CIK: 0001595989 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 19897875